SCHEMBL4487679

SCHEMBL4487679

CC(=O)N(CCCN(C)C)c1ccc(NC(=C2C(=O)Nc3cc(Cl)ccc32)c2cccc(CC(=O)O)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 4/20 0.37
PLK3 Q9H4B4 3/20 0.34
PDGFRB P09619 2/20 0.34
KIT P10721 2/20 0.34
FGFR1 P11362 2/20 0.34
KDR P35968 2/20 0.34
FLT3 P36888 2/20 0.34
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
NR1H4 Q96RI1 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LRRK2 Q5S007 1/20 0.32
SENP1 Q9P0U3 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
LCK P06239 1/20 0.31
TP53 P04637 2/20 0.31
FFAR1 O14842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4487674 1.00 PLK1 (0.37) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL4499221 0.95 PLK1 (0.35) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL4499224 0.95 PLK1 (0.35) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL226970 0.93 PLK1 (0.41) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL226971 0.93 PLK1 (0.41) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL4497412 0.92 NR1H4 (0.32) PLK1TMEM97SIGMAR1NR1H4RXFP1
SCHEMBL4497409 0.92 NR1H4 (0.32) PLK1TMEM97SIGMAR1NR1H4RXFP1
SCHEMBL4485666 0.92 KDM4E (0.35) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL4485660 0.92 KDM4E (0.35) PLK1PLK3PDGFRBKITFGFR1
SCHEMBL4488091 0.91 FLT3 (0.34) PDGFRBKDRFLT3KDM4ESENP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR PLK1 86/4885PLK3 133/4885PDGFRB 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.